Marc Machaalani, MD, on soluble MAdCAM-1 in metastatic renal cell carcinoma

In total, the study included 1051 patients. Data for the training cohort were obtained from the phase 3 JAVELIN Renal 101 trial (NCT02684006), and data for the validation cohorts were collected from the phase 2 SURF (NCT02689167) and NIVOREN…